Evidence map›Paper›PMID 35197297›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

Compartmentalized citrullination in Muller glial endfeet during retinal degeneration.

Sarah I Palko, Nicholas J Saba, Elias Mullane, Benjamin D Nicholas, Yosuke Nagasaka, Jayakrishna Ambati, Bradley D Gelfand, Akihito Ishigami, Paola Bargagna-Mohan, Royce Mohan

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. PARP inhibition preserves cone photoreceptors in rd2 retina.Acta neuropathologica communications · 2025
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Sarah I PalkoDepartment of Neuroscience, University of Connecticut Health Center, Farmington, CT 06030.ORCID 0000-0003-3862-8488
Nicholas J SabaDepartment of Neuroscience, University of Connecticut Health Center, Farmington, CT 06030.
Elias MullaneDepartment of Neuroscience, University of Connecticut Health Center, Farmington, CT 06030.
Benjamin D NicholasDepartment of Ophthalmology, University of Virginia Health System, Charlottesville, VA 22908.
Yosuke NagasakaDepartment of Ophthalmology, University of Virginia Health System, Charlottesville, VA 22908.
Jayakrishna AmbatiDepartment of Ophthalmology, University of Virginia Health System, Charlottesville, VA 22908.ORCID 0000-0003-1622-6365
Bradley D GelfandDepartment of Ophthalmology, University of Virginia Health System, Charlottesville, VA 22908.ORCID 0000-0003-4619-9409
Akihito IshigamiMolecular Regulation of Aging, Tokyo Metropolitan Institute of Gerontology, Tokyo 173-0015, Japan.ORCID 0000-0001-7875-7482
Paola Bargagna-MohanDepartment of Neuroscience, University of Connecticut Health Center, Farmington, CT 06030.
Royce MohanDepartment of Neuroscience, University of Connecticut Health Center, Farmington, CT 06030; mohan@uchc.edu.ORCID 0000-0002-5102-0437
UConn Health · USUniversity of Virginia Health System · USTokyo Metropolitan Institute of Gerontology · JP

Funding

PAD4 in Retinal GliosisR21EY028699 · NEI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI MOHAN, ROYCE · 2018 to 2019
$636k
Targeting Citrullination in Ocular Chemical InjuryR21EY032741 · NEI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI MOHAN, ROYCE · 2021 to 2022
$608k
NEI NIH HHS R21 EY028699NEI NIH HHS R21 EY032741
6 · The paper itself

Abstract

Muller glia (MG) play a central role in reactive gliosis, a stress response associated with rare and common retinal degenerative diseases, including age-related macular degeneration (AMD). The posttranslational modification citrullination​ targeting glial fibrillary acidic protein (GFAP) in MG was initially discovered in a panocular chemical injury model. Here, we report in the paradigms of retinal laser injury, a genetic model of spontaneous retinal degeneration (JR5558 mice) and human wet-AMD tissues that MG citrullination is broadly conserved. After laser injury, GFAP polymers that accumulate in reactive MG are citrullinated in MG endfeet and glial cell processes. The enzyme responsible for citrullination, peptidyl arginine deiminase-4 (PAD4), localizes to endfeet and associates with GFAP polymers. Glial cell-specific PAD4 deficiency attenuates retinal hypercitrullination in injured retinas, indicating PAD4 requirement for MG citrullination. In retinas of 1-mo-old JR5558 mice, hypercitrullinated GFAP and PAD4 accumulate in MG endfeet/cell processes in a lesion-specific manner. Finally, we show that human donor maculae from patients with wet-AMD also feature the canonical endfeet localization of hypercitrullinated GFAP. Thus, we propose that endfeet are a "citrullination bunker" that initiates and sustains citrullination in retinal degeneration.

Indexed as

CitrullinationAnimalsGliosisHumansMiceMice, Inbred C57BLMice, KnockoutNeurogliaRetinal DegenerationWet Macular DegenerationcitrullinationGFAPgliosisMuller glial endfeetretinal degeneration

Identifiers

PMID35197297
PMCPMC8917347
OpenAlexW4213457469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.